These Analysts Boost Their Forecasts On Aptiv After Upbeat Q4 Earnings

Core Insights - Aptiv PLC reported better-than-expected fourth-quarter earnings, with revenue of $5.153 billion, up from $4.907 billion a year earlier, reflecting a 3% increase on an adjusted basis [1][2] - The company experienced growth of 8% in North America and 12% in South America, while facing declines of 1% in Europe and Asia [1] - Fourth-quarter adjusted EPS was $1.86, beating the analyst estimate of $1.85, while revenue exceeded the estimate of $5.105 billion [2] Financial Guidance - For Q1 2026, Aptiv guided net sales between $4.950 billion and $5.150 billion, with U.S. GAAP diluted EPS forecasted at $0.60 to $0.80, and adjusted EPS at $1.55 to $1.75 [3] - For the full year 2026, the company forecasts net sales of $21.120 billion to $21.820 billion, with U.S. GAAP diluted EPS of $5.75 to $6.35, and adjusted EPS of $8.15 to $8.75 [3] Strategic Developments - The company is working towards the spin-off of its EDS business as Versigent, aiming to create two independent companies with increased flexibility for market opportunities and capital allocation strategies [4] - Following the earnings announcement, Aptiv shares gained 2.6%, trading at $80.08 [4] Analyst Ratings - Wells Fargo analyst maintained an Overweight rating on Aptiv and raised the price target from $99 to $102 [5] - Oppenheimer analyst maintained an Outperform rating and raised the price target from $102 to $106 [5]